Novartis Investigative Site

Dongjak Gu, Seoul 07061

2 studies enrolling now · 4 studies all time

What they study most

Huntington Disease, Non Alcoholic Steatohepatitis (NASH), Non-alcoholic Steatohepatitis (NASH), Papulopustular Rosacea

Studies at this site

• A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR) — Recruiting now
• A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease — Recruiting now
• Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. — Stopped early
• Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH) — Stopped early